Dislocation, Hip Clinical Trial
Official title:
Dual Mobility Acetabular Cups in Revision TJA
The aim of this study is to the compare clinical outcomes of patients undergoing a revision total hip arthroplasty (THA) with the use of a dual mobility bearing versus a single bearing design with the use of a large femoral head (36mm or 40mm). We hypothesize the use of dual-mobility components in revision THA will be associated with a lower dislocation rate in the first year following surgery.
Status | Recruiting |
Enrollment | 322 |
Est. completion date | October 1, 2034 |
Est. primary completion date | October 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Any patient older than 18 years of age scheduled for a revision THA, including revision of both components, conversion of a hip resurfacing to THA, conversion of a hemiarthroplasty to THA, and revision of single components which allow implantation of dual-mobility bearings. In addition, patients undergoing reimplantation of a total hip arthroplasty following a two-stage revision for periprosthetic infection will also be included. Only patients with an acetabular shell diameter capable of accommodating at least a 36mm femoral head will be included. Exclusion Criteria: - Less than 18 years of age, primary THA, - conversion of non-arthroplasty femoral neck fracture fixation to THA, - patients unwilling to participate. - patients where the surgeon makes the intraoperative decision to use a constrained liner will be excluded. |
Country | Name | City | State |
---|---|---|---|
United States | New York University Medical Center | New York | New York |
United States | Rothman Institute | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Rush University Medical Center | NYU Langone Health, Rothman Institute Orthopaedics |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Prosthetic Dislocation | The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits | 6 weeks | |
Primary | Prosthetic Dislocation | The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits | 3 months | |
Primary | Prosthetic Dislocation | The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits | 2 years | |
Primary | Prosthetic Dislocation | The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits | 5 years | |
Primary | Prosthetic Dislocation | The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits | 10 years | |
Primary | Prosthetic Dislocation | The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits | 15 years | |
Primary | Prosthetic Dislocation | The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits | 20 years | |
Secondary | Complications | Any peri- or postoperative complications will be recorded, including component loosening, occurrence of intraprosthetic dislocation, infection, periprosthetic fractures, revision rates | up to 20 years after the patient is discharged from the hospital | |
Secondary | Routine radiographs assess for loosening and proper component placement | Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. | 6 weeks | |
Secondary | Routine radiographs assess for loosening and proper component placement | Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. | 3 months | |
Secondary | Routine radiographs assess for loosening and proper component placement | Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. | 2 years | |
Secondary | Routine radiographs assess for loosening and proper component placement | Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. | 5 years | |
Secondary | Routine radiographs assess for loosening and proper component placement | Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. | 10 years | |
Secondary | Routine radiographs assess for loosening and proper component placement | Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. | 15 years | |
Secondary | Routine radiographs assess for loosening and proper component placement | Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. | 20 years. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04092634 -
Dual Mobility in "High Risk" Patients
|
Phase 4 | |
Enrolling by invitation |
NCT05587244 -
G7 Freedom Constrained Vivacit-E Liners
|
N/A | |
Enrolling by invitation |
NCT05548972 -
G7 Dual Mobility With Vivacit-E or Longevity PMCF
|
N/A | |
Not yet recruiting |
NCT04685239 -
Dual Mobility Cup Versus Unipolar Cup
|
N/A |